{"id":18923,"date":"2022-01-20T12:38:48","date_gmt":"2022-01-20T11:38:48","guid":{"rendered":"https:\/\/www.izb-online.de\/mediathek\/scg-cell-therapy-erweitert-die-globale-forschung-und-entwicklung-durch-die-eroeffnung-eines-forschungsstandortes-im-izb-in-deutschland\/"},"modified":"2022-01-20T12:49:09","modified_gmt":"2022-01-20T11:49:09","slug":"scg-cell-therapy-erweitert-die-globale-forschung-und-entwicklung-durch-die-eroeffnung-eines-forschungsstandortes-im-izb-in-deutschland","status":"publish","type":"gco_media","link":"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/","title":{"rendered":"SCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text el_class=”gco-magazine–title”]<\/p>\n

SCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany<\/h1>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine–post-date”]20.01.2022[\/vc_column_text][vc_column_text el_class=”gco-magazine-lead”]The Innovation and Start-up Center Biotechnology (IZB) is thus home to another biotech company conducting research in the field of immunotherapy[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy” css=”.vc_custom_1618289642146{margin-top: 22px !important;}”][vc_column_inner width=”2\/3″ offset=”vc_col-lg-6 vc_col-md-6″][vc_column_text]<\/p>\n


\nDownload Press Release<\/span><\/a><\/div>\n

[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″ offset=”vc_col-lg-6 vc_col-md-6″][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_single_image image=”18921″ img_size=”full”][vc_column_text css=”.vc_custom_1642679121463{margin-top: 12px !important;margin-bottom: 21px !important;}”]Dr. Karin Wisskirchen, Managing Director & Head of Research<\/em>
\nDr. Susanne Wilde, Head of Preclinical Research<\/em>
\nDr. Gregory Fanning, Acting-CEO<\/em>[\/vc_column_text][vc_column_text]SINGAPORE\/MUNICH, January 20, 2022 \u2013 Singapore-based SCG Cell Therapy Pte. Ltd. (\u201cSCG\u201d) has opened a new R&D site in the Innovation and Start-up Center Biotechnology in Martinsried\/Munich in Germany to accelerate SCG\u00b4s development of new immunotherapeutic candidates. The mission of the site is to expand the company\u00b4s portfolio of innovative products and platforms in the field of immunotherapy. The new R&D center in the Munich area focuses on the discovery and validation of new immunotherapeutic targets, generation of novel cell therapies and the development of related technologies.<\/strong><\/p>\n

Together with other sites in Singapore and China, SCG will be able to offer comprehensive solutions from research and discovery to regulatory and clinical development, marketing and commercialization. \u201cWe are excited to be opening a new research hub for SCG which contributes to completing our cell therapy pipeline ranging from T-cell receptor discovery to GMP-grade vector, TCR-T and CAR-T cell production,\u201d says Dr. Karin Wisskirchen, Managing Director and Head of Research of SCG Germany.<\/p>\n

\u201cInternal and external innovation are an integral part of our growth strategy and opening a research facility in Germany will boost our international R&D network particularly in Europe. It will also open up opportunities for SCG to attract top talent to join our mission to identify novel new cell therapies for patients and our pipeline,\u201d Dr. Greg Fanning an experienced international pharma expert and acting CEO of SCG Germany added.<\/p>\n

SCG stands for Singapore, China, Germany with each location having a significant place in SCG\u2019s foundation. Opening an additional site in Germany underlines company\u2019s strategic expansion at locations known for innovation in this field and facilitate the entry into global markets for the company clinical stage pipeline.<\/p>\n

SCG Cell Therapy GmbH will be located in Planegg\/Martinsried at the \u201dInnovation and Start-up Center Biotechnology\u201d (IZB), a leading center for biotechnology in Europe. Founded in 1995, IZB has grown to become one of the world’s top 10 biotechnology hubs and has produced a large number of successful businesses. The location provides the ideal infrastructure for biotech startups to transform their products or services into successful business propositions, within a competence cluster for life science ventures. Spanning across 26,000 m2<\/sup>, IZB is home to over 50 biotech companies.<\/p>\n

\u201cWe are glad to have established SCG Cell Therapy within Germany\u00b4s biotech hotspot, which will facilitate collaborations with strong academic and biotech partners in Munich\u201d, says Prof. Dr. Ulrike Protzer, Director of the Institute of Virology of the Technical University of Munich and the Helmholtz Center Munich, and Scientific Founder of SCG. SCG\u00b4s founding technology originates from intensive research in Munich, and maintains strong links through collaborations.<\/p>\n

Sharing his thoughts on SCG\u2019s establishment in IZB, Dr. Peter Hanns Zobel, Managing Director of IZB said, \u201cWe are overjoyed to be able to support such a motivated biotech company. SCG\u2019s pipeline and international network make success tangible\u201d.<\/p>\n

About SCG Cell Therapy:
\n<\/strong>SCG is a rapidly evolving biotechnology company focusing on the development of novel immunotherapies for patients with infections and infection-associated cancer. Established and headquartered in Singapore, SCG has a strong footprint and scientific network in Singapore, China and Germany. The company develops T cell therapies, bispecific antibodies, and therapeutic vaccines for hepatitis B, helicobacter pylori and human papillomavirus infection and associated malignancies, which attribute to high burden of diseases worldwide. SCG\u2019s scientific founder is Prof. Dr. Ulrike Protzer, a leading virologist and director of the Institute of Virology of the Technical University of Munich and of the Institute of Virology of the Helmholtz Center Munich.<\/p>\n

Contact:<\/strong>
\nSCG Cell Therapy Pte Ltd
\n50 Raffles Place
\n#37-00 Singapore Land Tower
\nSingapore 048623<\/p>\n

phone + 65 6829 7180
\nfax + 65 6829 7070
\ninfo@scgcell.com<\/a>
\nwww.scgcell.com<\/a><\/p>\n

 <\/p>\n

SCG Cell Therapy GmbH
\nAm Klopferspitz 19
\n81252 Planegg
\nphone +49 89 7007 6625
\ninfo.de@scgcell.com<\/a>
\nwww.scgcell.com<\/a><\/p>\n

Disclaimer:
\n<\/strong>This press release may contain forward-looking statements and information which are based on our current expectations and certain assumptions. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, performance of the company, development of the products and the estimates given here. Such known and unknown risks and uncertainties comprise, among others, the research and development, the regulatory approval process, the timing of the actions of regulatory bodies and other governmental authorities, clinical results, changes in laws and regulations, product quality, patient safety, patent litigation, contractual risks and dependencies from third parties. With respect to pipeline products, SCG Cell Therapy Pte Lte does not provide any representation, warranties or any other guarantees that the products will receive the necessary regulatory approvals or that they will prove to be commercially exploitable and\/or successful. SCG Cell Therapy assumes no obligation to update these forward-looking statements or to correct them in case of developments which differ from those anticipated.<\/p>\n

About Innovation and Start-up Center for Biotechnology (IZB) in Martinsried near Munich
\n<\/strong>The IZB was founded in 1995 and is located in Planegg-Martinsried and Freising-Weihenstephan, and has developed into a leading biotechnology center in Europe. More than 50 biotech companies with over 700 employees are currently located on 26,000 m2 <\/sup>of land. Here, work focuses on the development of drugs against the most serious diseases, such as cancer, Alzheimer’s and various autoimmune diseases. A key criterion for the success of the IZBs is their close proximity to top-level research at both the Martinsried\/Grosshadern campus and the Weihenstephan campus. The new infrastructure measures such as the Faculty Club G2B (Gateway to Biotech), the IZB Residence CAMPUS AT HOME, the Elhardt Chemistry College, the two kindergartens Bio Kids and Bio Kids2<\/sup>, as well as the two restaurants SEVEN AND MORE and Caf\u00e9 Freshmaker are also location factors that are highly appreciated by the company founders. Successful companies that have emerged from the IZB include Medigene AG, MorphoSys AG, Micromet GmbH (today Amgen AG), Octopharma GmbH, Corimmun (today Janssen-Cilag), Rigontec GmbH (today MSD), ibidi GmbH, Coriolis GmbH and Immunic Therapeutics. More information at www.izb-online.de<\/a><\/p>\n

Press contact and image requests:
\n<\/strong>Susanne Simon, Head of Public Relations
\nF\u00f6rdergesellschaft IZB mbH, Am Klopferspitz 19, D-82152 Planegg Martinsried
\nPhone: +49 (0)89\/55 279 48-17,
\nE-mail: simon@izb-online.de<\/a>
\n<\/u>www.izb-online.de<\/a>[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"featured_media":18650,"template":"","meta":{"_links_to":"","_links_to_target":""},"media-categories":[7432,7431],"class_list":["post-18923","gco_media","type-gco_media","status-publish","has-post-thumbnail","hentry","media-categories-press-release","media-categories-press-release-izb-martinsried"],"yoast_head":"\nSCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany\" \/>\n<meta property=\"og:description\" content=\"SCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany 20.01.2022The Innovation and Start-up Center\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-20T11:49:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.izb-online.de\/wp-content\/uploads\/2021\/11\/SCG-logo-mittel-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1195\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/pressemeldung\\\/pressemeldung-izb-martinsried\\\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/pressemeldung\\\/pressemeldung-izb-martinsried\\\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\\\/\",\"name\":\"SCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/pressemeldung\\\/pressemeldung-izb-martinsried\\\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/pressemeldung\\\/pressemeldung-izb-martinsried\\\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/SCG-logo-mittel-scaled.jpg\",\"datePublished\":\"2022-01-20T11:38:48+00:00\",\"dateModified\":\"2022-01-20T11:49:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/pressemeldung\\\/pressemeldung-izb-martinsried\\\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/pressemeldung\\\/pressemeldung-izb-martinsried\\\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/pressemeldung\\\/pressemeldung-izb-martinsried\\\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/SCG-logo-mittel-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/SCG-logo-mittel-scaled.jpg\",\"width\":2560,\"height\":1195,\"caption\":\"SCG Logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/pressemeldung\\\/pressemeldung-izb-martinsried\\\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PRESS RELEASE\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/media-library\\\/press-release\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Press release standard\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/media-library\\\/press-release\\\/press-release-izb-martinsried\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"SCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"name\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"description\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\",\"name\":\"F\u00f6rdergesellschaft IZB mbH\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"F\u00f6rdergesellschaft IZB mbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/","og_locale":"en_US","og_type":"article","og_title":"SCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany","og_description":"SCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany 20.01.2022The Innovation and Start-up Center","og_url":"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/","og_site_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","article_modified_time":"2022-01-20T11:49:09+00:00","og_image":[{"width":2560,"height":1195,"url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2021\/11\/SCG-logo-mittel-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/","url":"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/","name":"SCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/#primaryimage"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2021\/11\/SCG-logo-mittel-scaled.jpg","datePublished":"2022-01-20T11:38:48+00:00","dateModified":"2022-01-20T11:49:09+00:00","breadcrumb":{"@id":"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/#primaryimage","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2021\/11\/SCG-logo-mittel-scaled.jpg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2021\/11\/SCG-logo-mittel-scaled.jpg","width":2560,"height":1195,"caption":"SCG Logo"},{"@type":"BreadcrumbList","@id":"https:\/\/www.izb-online.de\/en\/mediathek\/pressemeldung\/pressemeldung-izb-martinsried\/scg-cell-therapy-expands-global-rd-by-opening-a-research-innovation-site-at-the-izb-in-germany\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.izb-online.de\/en\/"},{"@type":"ListItem","position":2,"name":"PRESS RELEASE","item":"https:\/\/www.izb-online.de\/en\/media-library\/press-release\/"},{"@type":"ListItem","position":3,"name":"Press release standard","item":"https:\/\/www.izb-online.de\/en\/media-library\/press-release\/press-release-izb-martinsried\/"},{"@type":"ListItem","position":4,"name":"SCG Cell Therapy expands global R&D by opening a research innovation site at the IZB in Germany"}]},{"@type":"WebSite","@id":"https:\/\/www.izb-online.de\/en\/#website","url":"https:\/\/www.izb-online.de\/en\/","name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"Innovations- und Gr\u00fcnderzentrum Biotechnologie","publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.izb-online.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.izb-online.de\/en\/#organization","name":"F\u00f6rdergesellschaft IZB mbH","url":"https:\/\/www.izb-online.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","width":1,"height":1,"caption":"F\u00f6rdergesellschaft IZB mbH"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/gco_media\/18923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/gco_media"}],"about":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/types\/gco_media"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media\/18650"}],"wp:attachment":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media?parent=18923"}],"wp:term":[{"taxonomy":"media-categories","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media-categories?post=18923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}